3386 is the number to watch for that s p 500 record close. 59 minutes until the close we have a big show coming up to day the s p 500 makes yet another run at that record close bob doll will tell us why he is expecting the economic recovery to be more choppy. And why hes cautious in the short term plus, gaming the impact of the dnc. Well speak with a policy expert who says this weeks Democratic National convention could be a negative for the market even though its happening virtually. Right now, were going to focus in on the big stories were watching to day. Bob pisani is tracking to days action we have the latest on growing tensions with china. And joining us with his outlook for stocks is tony dwyer bob, start us off with the Broader Market whats going on behind the scenes and whether you think we could see that record s p 500 close today. When you get this close within less than 1 he , you usuy can get over it. Were still not there. 3386 as you heard before is the old closing high t
Amgen, genentech, gilead, regeneron, four of the greatest in the world for doing exactly what theyre doing. And currently 10 different therapeutic agents are in active trials an some are looking incredibly successful we have to go through a process. It will be a fairly quick process, i tell you based on what the fda told me. 15 are in plans for clinical trials. Theyre advancing rapidly. A Second Company announced that the fda authorized it is vaccine candidate to begin clinical trials. Johnson johnson is already there. I believe theyre the one thats first and now we have a Second Company that Just Announced and we were just, was just approved. So we have two companies at that level, for the vaccine itself. We have you no performed 100, well, if you think of this, 1. 79 million tests. That is one million, 790,000 tests nationwide. I think were going to put up a screen here someplace that theyre on cue, just on cue. And here it is. This is the process starting on 5 march and ending right
Regeneron, four of the greatest in the world for doing exactly what theyre doing. And currently 10 different therapeutic agents are in active trials an some are looking incredibly successful we have to go through a process. It will be a fairly quick process, i tell you based on what the fda told me. 15 are in plans for clinical trials. Theyre advancing rapidly. A Second Company announced that the fda authorized it is vaccine candidate to begin clinical trials. Johnson johnson is already there. I believe theyre the one thats first and now we have a Second Company that Just Announced and we were just, was just approved. So we have two companies at that level, for the vaccine itself. We have you no performed 100, well, if you think of this, 1. 79 million tests. That is one million, 790,000 tests nationwide. I think were going to put up a screen here someplace that theyre on cue, just on cue. And here it is. This is the process starting on 5 march and ending right there, right about now, r
Regeneron, four of the greatest in the world for doing exactly what theyre doing. And currently 10 different therapeutic agents are in active trials an some are looking incredibly successful we have to go through a process. It will be a fairly quick process, i tell you based on what the fda told me. 15 are in plans for clinical trials. Theyre advancing rapidly. A Second Company announced that the fda authorized it is vaccine candidate to begin clinical trials. Johnson johnson is already there. I believe theyre the one thats first and now we have a Second Company that Just Announced and we were just, was just approved. So we have two companies at that level, for the vaccine itself. We have you no performed 100, well, if you think of this, 1. 79 million tests. That is one million, 790,000 tests nationwide. I think were going to put up a screen here someplace that theyre on cue, just on cue. And here it is. This is the process starting on 5 march and ending right there, right about now, r
Gilead, regeneron, four of the greatest in the world, amgen, currently ten different trials and some are looking incredibly successful. We have to go through process of its going to be a fairly quick process, i will tell you, basin with the fda told me. And another 15 are in plans for clinical trials. They are advancing rapidly. Today a Second Company announced that the fda has organized its vaccine candidates to begin clinical trials. You have Johnson Johnson already there. I believe they are the one thats first. And now we have a Second Company that just announced, and we it was just approved. We have two companies at that level for the vaccine. We have not performed 100, well, if you think of this, 1. 79 million tests. 1,790,000 tests nationwide and i think we are going to put up a screen here someplace. They are on cue. Here it is. This is the process starting on 5 march and ending right there right about now. Psalm, and its going up at a rapid rate. Nobody has done more testing. O